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Abstract 
Purpose 
To assess the yearly incidence of vitrectomy for proliferative diabetic retinopathy 
over an 11 year period, in a geographically defined part of North East England. The 
time period covered the introduction of diabetic retinopathy screening. 
Methods 
All patients undergoing vitrectomy for diabetic retinopathy in the Sunderland and 
South Tyneside area were recorded from 2000 to 2010. Incidence rates of vitrectomy 
specifically for the complications of proliferative diabetic retinopathy for the observed 
diabetic population, the estimated diabetic population and the population with known 
proliferative diabetic retinopathy (PDR) were calculated. 
Results 
There was a gradual and significant decline in the vitrectomy rate from 157 (95% 
confidence limits 135-187) to 103 (98-109) per 100,000 of the observed diabetic 
population in 2000 and 2010 respectively. The rate in the estimated diabetic 
population showed no significant change at 68 (48-87) in 2002 and 77 (55-103) in 
2010. The rate in the PDR population, which comprised 2.4% of the known diabetic 
population in 2002 and 1.8% in 2010, declined significantly from 7.7% in 2002 to 
5.7% in 2010. 
Conclusion 
This study evaluated vitrectomy rates for proliferative diabetic retinopathy in an area 
of North East England. There were apparent declining rates of vitrectomy for PDR 
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following the introduction of diabetic retinopathy screening but these have to be 
interpreted in the light of several confounding factors.  
 
Key words: diabetic population; diabetic retinopathy; incidence; prevalence; diabetic 
vitrectomy. 
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Introduction 
Although vitrectomy is a proven and effective treatment for the complications of 
proliferative diabetic retinopathy (PDR)1, the proportion of patients requiring the 
procedure is poorly defined. Some vitrectomies are probably inevitable despite 
optimum treatment. Indeed, 4% of eyes treated with laser for high risk PDR in the 
Early Treatment Diabetic Retinopathy Study (ETDRS)1 went on to require vitrectomy 
within 5 years despite the rigid inclusion criteria and protocol follow up. Several 
modifiable factors are likely to influence the rate of vitrectomy in PDR, these include 
glycaemic and hypertensive control, screening for early sight-threatening retinopathy 
and attendance for, and adequacy of laser treatment.2 Thus in the ‘real world’ 
vitrectomy rate is probably variable and higher than found in the ETDRS. Indeed 
Kaiser et al. reported that 10% of patients presenting de novo with any stage of PDR 
in a tertiary referral centre in the USA required vitrectomy within 1 year of 
presentation.3 The yearly overall population rate of vitrectomy for PDR will also be 
affected by the known increasing prevalence of diabetes and furthermore the rate in 
the diabetic population will be affected by the size of the true diabetic population as 
opposed to the known observed diabetic population, between which there is known 
to be a variable mismatch.4 To add to the complexity of the situation, the indications 
for vitrectomy surgery are gradually evolving with non PDR related tractional macular 
oedema now being routinely operated upon.5, 6, 7. Finally, there has been a steady 
reduction in the surgical complication rate 6-8 meaning that a lowering of the 
threshold for surgery has probably occurred.  
We devised this study to assess the yearly incidence rate of diabetic vitrectomy in a 
defined geographical area over an 11 year period. Importantly, the period covered 
the introduction of systematic diabetic retinopathy screening into the area in 2002.  
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Method 
The population studied was the Sunderland and South Tyneside primary care trust 
areas of North East England which had a total over 16 years old population of 
355,254 in 2000 and 403,754 in 2010.9 Vitrectomy was carried out at Sunderland 
Eye Infirmary by the same three surgeons during the study period. All vitrectomies 
carried out on patients with diabetic retinopathy from January 2000 to Dec 2010 
were collated using surgical databases and searching of theatre lists during the 
period. Case notes and audit forms were examined to check the indications for 
surgery. Cases where the primary indication was not diabetic retinopathy were 
excluded, and cases where surgery was performed for non PDR associated traction 
were identified. . Patients’ postcodes were recorded and patients outside the 
catchment area were excluded. The area studied was surrounded by localities also 
served by Sunderland Eye Infirmary but the completeness of case finding was also 
checked in two other ways. Neighbouring units and private providers carrying out 
vitrectomy were asked to check for cases in the postcode area during the study 
period. As part of the local screening service, patients with diabetes requiring 
vitrectomy were collated yearly from 2002 and these lists and the current register 
were examined for any extra cases. 
Local over 16 year old prevalence figures from practice registers were used to 
calculate the observed diabetes prevalence within the PCT areas.  The UK 
Association of Public Health Observatories (APHO) Diabetes Prevalence model was 
used to estimate true diabetes prevalence in 2001 and 2010 in the area studied. This 
prevalence model is based on data from the Health Survey for England and takes 
into account age, sex, ethnicity, deprivation and obesity trends in individual localities. 
The model provides uncertainty limits around the point prevalence estimates and 
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uses a definition of diabetes based on either self-reported doctor diagnosis of 
diabetes or an HbA1c of 48 mmol ⁄ mol (6.5%) or greater, in keeping with 
recommendations from the American Diabetes Association. 10 
Data from the local Diabetic retinopathy screening service were used to calculate 
local prevalence of PDR in 2002 and 2010. These were cross checked with hospital 
data to ensure accuracy. Only the first eye of patients undergoing vitrectomy was 
included in the analysis and rates are given per person. To assess relevant 
demographic changes in the population undergoing vitrectomy, a detailed audit of 
the indications, presentation, systemic control and other variables was carried out on 
patients having vitrectomy in 2000 and 2001 and then in 2009 and 2010. The study 
complies with the tenets of the Declaration of Helsinki. All data used in this study 
were anonymised and collected as part of routine care and was thus classified as 
audit confirmed by the Sunderland Area Ethics Committee. 
 
Statistical analysis 
Differences in variables between the two audit periods were compared using non 
paired t test for continuous variables, and Fisher’s exact test for categorical data. 
Pearson’s correlation coefficient was used to examine the relationship between 
vitrectomy rate and year.  
 
Results  
The observed local over 16 year old diabetes prevalence in Sunderland increased 
from 2.8% in 2000 to 5.5% in 2010. The corresponding figures in South Tyneside 
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were 3% increasing to 6.2%. The estimated prevalence of diabetes was 6.8% (95% 
uncertainty limits 5.3-9.6%) and 7.3% (5.7-10.4%) in Sunderland and South 
Tyneside respectively in 2001 and 7.6% (5.7-10.7%) and 8% (5.9-11.3%) in 2010. 
During the eleven year study period there were 226 first eye vitrectomies performed 
for the complications of PDR with a further 35 performed for non PDR associated 
macular traction. The percentage of the diabetic population with PDR was calculated 
to be 2.4% in 2002 and 1.8% in 2010. Table 1 shows the yearly population numbers 
observed diabetes prevalence, estimated prevalence and percentage of patients with 
PDR.  
Table 2 shows the rates of vitrectomy for PDR in the observed diabetic population, 
the PDR population and the estimated diabetic population. The rate of vitrectomy in 
the observed diabetic population was 157(135-187) per 100,000 in 2000 and 103(98-
109) per 100,000 in 2010. There was a significant downwards trend in the rate of 
vitrectomy from 2000 to 2010 in vitrectomies for the complications of PDR in the 
observed diabetic population (Pearson’s r = -0.729, p=0.011).  (Figure 1) although 
the point rate of vitrectomy between 2000 and 2010 was not significantly different (p 
= 0.23, 95% CI = 0.75 to 2.98). The number of patients with PDR requiring 
vitrectomy showed a significant reduction from 7.7% in 2002 to 5.7% in 2010. (OR = 
1.81, p < .0001 respectively). There was no significant change in the rate of 
vitrectomy in the estimated diabetic population from 68 (48-87) per 100,000 in 2001 
to 77(55-103) in 2010 (p=0.51).  
Table 3 presents detailed data on the 34 patients who underwent vitrectomy in 2000-
2001 and the 59 patients who underwent vitrectomy in 2009-2010. There were 
significant reductions in mean HbA1c at vitrectomy and the percentage of patients 
undergoing vitrectomy who presented with established proliferative diabetic 
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retinopathy. Similarly, there was a significant increase in the duration of known 
diabetes prior to vitrectomy and evidence of a lowering of the surgical threshold with 
an improvement in visual acuities prior to vitrectomy. In 2000/1 79% of cases had a 
visual acuity of 6/60 or worse prior to vitrectomy compared to 49% in 2009/10.  
 
Discussion 
The rate for vitrectomy for PDR in the observed diabetic population in 2010 was 103 
per 100,000 of the diabetic population. There is little to compare this with in the 
published literature. Gupta et al. 6 found a rate of 200; higher than our rate but 
broadly in the same range. It should be noted that the actual rate of diabetic 
vitrectomy in the area was higher because 34% of patients underwent fellow eye 
surgery, concurring with previous studies11 and 6% underwent revision surgery for 
various post-operative problems. There are several reasons why vitrectomy rate may 
vary between areas, including the ethnicity of the studied population. The area of 
North East England studied in this paper was predominantly (95.5%) white 
Caucasian compared to the UK average of 88.2% 12 and 67% in the study by Gupta 
et al.6  
We found a rate of vitrectomy for PDR of 5.7% in 2010. This compared to the 5 year 
vitrectomy rate of 5.3% per person with PDR reported by ETDRS with a cumulative 
rate of 11% at 9 years1, and Kaiser et al.’s3 reported 10% within 1 year of 
presentation with any stage of PDR. It is difficult to know the exact relationship 
between the prevalence of PDR in a population and the number of patients requiring 
vitrectomy as we have done, compared with following a cohort of patients with PDR 
but it is interesting that they fall within the same range. 
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The rate of vitrectomy for PDR showed a gradual reduction from 157 in 2000 to 103 
in 2010. This was mirrored by a falling rate in the PDR population from 7.7% in 2002 
to 5.7% in 2010. Screening was introduced in 2002 which accounts for the number of 
patients undergoing vitrectomy in 2000/2001 who were referred with PDR at 
presentation being substantially higher than in 2009/10 suggesting that earlier 
retinopathy was being detected and referred after the onset of screening. There are, 
however, several other potential reasons for the vitrectomy rate falling. Scanlon 
divided the reasons for eyes requiring vitrectomy into potentially modifiable and non-
modifiable factors 2. Non modifiable factors include the ethnicity of the population 
and the duration of diabetes. The ethnicity of the area was fairly static according to 
census data 9 but diabetes duration in those undergoing vitrectomy did increase from 
2000/1 to 2009/10 perhaps secondary to diabetic care improving and length time 
bias with earlier diagnosis of diabetes. Potentially modifiable factors include 
metabolic and hypertensive control and laser treatment. HbA1C in those undergoing 
vitrectomy improved from 2000/1 to 2009/10 and there is also evidence locally that 
HbA1C control improved over the study period.13,14 Long term progression rates to 
PDR have reduced as metabolic and hypertensive control has improved over the last 
25-30 years and this would also be expected to result in a reducing vitrectomy rate 
15,16. 
The study has several weaknesses in that it was a retrospective observational study 
of standard clinical practice. There were no predefined protocols for which patients 
were eligible for vitrectomy and it is well known that surgeons vary in their surgical 
intervention rates.17 However, the same surgeons were involved with the care of the 
patients during the study period and although there is evidence that the surgical 
threshold reduced during the 11 years, the variability will have been less than if 
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different surgeons had been involved We did not record patients who declined 
surgery despite being offered it and we do not know the number of patients for whom 
it was felt that the disease was too advanced to benefit from surgery. 
There are also two other confounders which may have influenced the results. Firstly, 
there is evidence that the threshold for vitrectomy is decreasing with improving 
preoperative visual acuities, as noted elsewhere 5, 7.If the indications for vitrectomy 
used in 2000 had stayed constant then the rate in 2010 would have fallen 
considerably more than reported here. Importantly, we distinguished vitrectomy for 
PDR-related complications from vitrectomy for non PDR associated foveal traction, a 
relatively new indication for surgery. Secondly, an additional confounder is the 
prevalence of diabetes used. It is widely acknowledged that there is a mismatch 
between the true number of patients with diabetes and those actually diagnosed. 
Diabetes prevalence models provide an estimate of total (diagnosed and 
undiagnosed) diabetes prevalence within a population. Recently, the UK Association 
of Public Health Observatories (APHO) produced a new diabetes prevalence model4 
which has been validated in an adjacent area of North East England.18 The gap 
between the observed and estimated diabetic population was lower between study 
onset and finish and there is a lower proportion of undiagnosed diabetics in the area 
now than in 2000. This could in part explain the falling rate in the observed diabetic 
population with fewer patients presenting at diagnosis with advanced retinopathy and 
also a length time bias, with a greater number of early milder diabetics included in 
the population prevalence figures. Indeed our vitrectomy incidence figures, based on 
the estimated diabetes prevalence albeit with their wide uncertainty limits, show no 
significant reduction and our reducing incidence of PDR also confers with this. It 
seems likely that even if modifiable factors continue to improve, some patients will 
 11 
still require vitrectomy either from retinal neovascularisation progressing despite 
laser or the later effects of vitreous separation.1,19 Patient factors also moderate the 
effects of improving access to healthcare and the resultant requirement for 
vitrectomy. The uptake of screening in the area was 89% in 2010 despite a wide 
variety of interventions to improve uptake, and furthermore failure to attend 
appointments is common. 
The strengths of the study include that the area studied had low population growth 
over the study period with low migration into and out of the area. It was also a 
circumscribed area served by one eye unit. Case finding was based on surgeon 
records and cross checked with theatre diaries, neighbouring providers, diabetic 
vitrectomy annual screening lists and the current screening database which records 
if diabetic vitrectomy has been carried out, meaning that the chance of missed cases 
was low.  
In conclusion, this study evaluated vitrectomy rates for diabetic retinopathy in an 
area of North East England. Rates for a diabetic population over an 11 year period 
are produced for the first time. There was a suggestion of declining rates of 
vitrectomy for PDR in patients with diabetes following the introduction of diabetic 
retinopathy screening, although several confounding factors have to be considered.  
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